Cargando…
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations
Cancer is still a major barrier to life expectancy increase worldwide, and hematologic neoplasms represent a relevant percentage of cancer incidence rates. Tumor dependence of continuous proliferative signals mediated through protein kinases overexpression instigated increased strategies of kinase i...
Autores principales: | Machado, Caio Bezerra, de Pinho Pessoa, Flávia Melo Cunha, da Silva, Emerson Lucena, da Costa Pantoja, Laudreísa, Ribeiro, Rodrigo Monteiro, de Moraes Filho, Manoel Odorico, de Moraes, Maria Elisabete Amaral, Montenegro, Raquel Carvalho, Burbano, Rommel Mário Rodriguez, Khayat, André Salim, Moreira-Nunes, Caroline Aquino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540545/ https://www.ncbi.nlm.nih.gov/pubmed/34683897 http://dx.doi.org/10.3390/pharmaceutics13101604 |
Ejemplares similares
-
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution
por: de Pinho Pessoa, Flávia Melo Cunha, et al.
Publicado: (2022) -
The Role of WRAP53 in Cell Homeostasis and Carcinogenesis Onset
por: Gadelha, Renan Brito, et al.
Publicado: (2022) -
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022) -
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives
por: Barreto, Igor Valentim, et al.
Publicado: (2022) -
Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia
por: Nogueira, Beatriz Maria Dias, et al.
Publicado: (2021)